Brooke A Jarrett1, Sarah M Peitzmeier2, Arjee Restar1, Tyler Adamson3, Sean Howell4, Stefan Baral1, S Wilson Beckham5. 1. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, United States of America. 2. Department of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, Michigan, United States of America. 3. Department of Health, Policy, and Management, Johns Hopkins School of Public Health, Baltimore, MD, United States of America. 4. Hornet, San Francisco, CA, United States of America. 5. Department of Health, Behavior, and Society, Department of International Health, Johns Hopkins School of Public Health, Baltimore, MD, United States of America.
Abstract
BACKGROUND: Transgender and nonbinary people are disproportionately affected by structural barriers to quality healthcare, mental health challenges, and economic hardship. This study examined the impact of the novel coronavirus disease (COVID-19) crisis and subsequent control measures on gender-affirming care, mental health, and economic stability among transgender and nonbinary people in multiple countries. METHODS: We collected multi-national, cross-sectional data from 964 transgender and nonbinary adult users of the Hornet and Her apps from April to August 2020 to characterize changes in gender-affirming care, mental health, and economic stability as a result of COVID-19. We conducted Poisson regression models to assess if access to gender-affirming care and ability to live according to one's gender were related to depressive symptoms, anxiety, and changes in suicidal ideation. RESULTS: Individuals resided in 76 countries, including Turkey (27.4%, n = 264) and Thailand (20.6%, n = 205). A majority were nonbinary (66.8%, n = 644) or transfeminine (29.4%, n = 283). Due to COVID-19, 55.0% (n = 320/582) reported reduced access to gender-affirming resources, and 38.0% (n = 327/860) reported reduced time lived according to their gender. About half screened positive for depression (50.4%,442/877) and anxiety (45.8%, n = 392/856). One in six (17.0%, n = 112/659) expected losses of health insurance, and 77.0% (n = 724/940) expected income reductions. The prevalence of depressive symptoms, anxiety, and increased suicidal ideation were 1.63 (95% CI: 1.36-1.97), 1.61 (95% CI: 1.31-1.97), and 1.74 (95% CI: 1.07-2.82) times higher for individuals whose access to gender-affirming resources was reduced versus not. DISCUSSION: The COVID-19 crisis is associated with reduced access to gender-affirming resources and the ability of transgender and nonbinary people to live according to their gender worldwide. These reductions may drive the increased depressive symptoms, anxiety, and suicidal ideation reported in this sample. To improve health of transgender and nonbinary communities, increased access to gender-affirming resources should be prioritized through policies (e.g., digital prescriptions), flexible interventions (e.g., telehealth), and support for existing transgender health initiatives.
BACKGROUND: Transgender and nonbinary people are disproportionately affected by structural barriers to quality healthcare, mental health challenges, and economic hardship. This study examined the impact of the novel coronavirus disease (COVID-19) crisis and subsequent control measures on gender-affirming care, mental health, and economic stability among transgender and nonbinary people in multiple countries. METHODS: We collected multi-national, cross-sectional data from 964 transgender and nonbinary adult users of the Hornet and Her apps from April to August 2020 to characterize changes in gender-affirming care, mental health, and economic stability as a result of COVID-19. We conducted Poisson regression models to assess if access to gender-affirming care and ability to live according to one's gender were related to depressive symptoms, anxiety, and changes in suicidal ideation. RESULTS: Individuals resided in 76 countries, including Turkey (27.4%, n = 264) and Thailand (20.6%, n = 205). A majority were nonbinary (66.8%, n = 644) or transfeminine (29.4%, n = 283). Due to COVID-19, 55.0% (n = 320/582) reported reduced access to gender-affirming resources, and 38.0% (n = 327/860) reported reduced time lived according to their gender. About half screened positive for depression (50.4%,442/877) and anxiety (45.8%, n = 392/856). One in six (17.0%, n = 112/659) expected losses of health insurance, and 77.0% (n = 724/940) expected income reductions. The prevalence of depressive symptoms, anxiety, and increased suicidal ideation were 1.63 (95% CI: 1.36-1.97), 1.61 (95% CI: 1.31-1.97), and 1.74 (95% CI: 1.07-2.82) times higher for individuals whose access to gender-affirming resources was reduced versus not. DISCUSSION: The COVID-19 crisis is associated with reduced access to gender-affirming resources and the ability of transgender and nonbinary people to live according to their gender worldwide. These reductions may drive the increased depressive symptoms, anxiety, and suicidal ideation reported in this sample. To improve health of transgender and nonbinary communities, increased access to gender-affirming resources should be prioritized through policies (e.g., digital prescriptions), flexible interventions (e.g., telehealth), and support for existing transgender health initiatives.
Authors: Nana Ernst Toldam; Christian Graugaard; Rikke Meyer; Louise Thomsen; Sabine Dreier; Emmanuele A Jannini; Annamaria Giraldi Journal: Sex Med Rev Date: 2022-06-30
Authors: Marta Mirabella; Giulia Senofonte; Guido Giovanardi; Vittorio Lingiardi; Alexandro Fortunato; Francesco Lombardo; Anna Maria Speranza Journal: Sex Res Social Policy Date: 2021-08-14
Authors: Lori A Brotto; Kyle Chankasingh; Alexandra Baaske; Arianne Albert; Amy Booth; Angela Kaida; Laurie W Smith; Sarai Racey; Anna Gottschlich; Melanie C M Murray; Manish Sadarangani; Gina S Ogilvie; Liisa Galea Journal: PLoS One Date: 2021-11-22 Impact factor: 3.240
Authors: Daria Szücs; Andreas Köhler; Mika M Holthaus; Annette Güldenring; Lena Balk; Joz Motmans; Timo O Nieder Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2021-10-07 Impact factor: 1.513
Authors: Christian Grov; Fatima Zohra; Drew A Westmoreland; Chloe Mirzayi; Alexa D'Angelo; Matthew Stief; Sarah Kulkarni; Denis Nash; Adam W Carrico Journal: Arch Sex Behav Date: 2021-11-29